Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Care Heartburn Relief oral suspension
0101021B0BTAAAH
|
Care Heartburn Relief | Alginic acid compound preparations | Gastro-Intestinal System | 1 |
|
Carexil 10mg modified-release tablets
0407020ADBDABAF
|
Carexil | Oxycodone hydrochloride | Central Nervous System | 1 |
|
Carolon compression understocking pack short/regular size B
21200000141
|
Carolon compression understocking pack short/regular size B | Venous Ulcer Compression System | Appliances | 1 |
|
Carolon compression understocking pack short/regular size C
21200000142
|
Carolon compression understocking pack short/regular size C | Venous Ulcer Compression System | Appliances | 1 |
|
Carolon compression understocking pack short/regular size D
21200000143
|
Carolon compression understocking pack short/regular size D | Venous Ulcer Compression System | Appliances | 1 |
|
Carolon compression understocking pack short/regular size G
21200000146
|
Carolon compression understocking pack short/regular size G | Venous Ulcer Compression System | Appliances | 1 |
|
Carolon graduated compression system size F
21200000065
|
Carolon graduated compression system size F | Venous Ulcer Compression System | Appliances | 1 |
|
Catapres 150micrograms/1ml solution for injection ampoules
0205020E0BBADAB
|
Catapres | Clonidine hydrochloride | Cardiovascular System | 1 |
|
Catapres TTS 2 patches
0205020E0BBAFAG
|
Catapres | Clonidine hydrochloride | Cardiovascular System | 1 |
|
Cefaclor 250mg capsules
0501021A0AAAAAA
|
Cefaclor | Cefaclor | Infections | 1 |
|
Ceftazidime 3g powder for solution for injection vials
0501021H0AAAHAH
|
Ceftazidime pentahydrate | Ceftazidime pentahydrate | Infections | 1 |
|
CelluDress dressing 15cm x 20cm
20030100595
|
CelluDress dressing 15cm x 20cm | Wound Management & Other Dressings | Dressings | 1 |
|
Centrum Kidz chewable tablets
090607000BBKKA0
|
Proprietary compound preparation BNF 0906070 | Other multivitamin preparations | Nutrition and Blood | 1 |
|
Cervarix vacc inj 0.5ml pre-filled syringes
1404000AIBBAAAA
|
Cervarix | Human papillomavirus (Type 16,18) | Immunological Products and Vaccines | 1 |
|
Cetrorelix 250microgram inj vials
0607020D0AAAAAA
|
Cetrorelix | Cetrorelix | Endocrine System | 1 |
|
Cetrotide 250microgram inj vials
0607020D0BBAAAA
|
Cetrotide | Cetrorelix | Endocrine System | 1 |
|
Chailey adult pubic pressure flange curved top 29mm
22902409116
|
Chailey adult pubic pressure flange curved top 29mm | Urinal Systems | Incontinence Appliances | 1 |
|
Chailey adult pubic pressure flange curved top 32mm
22902409117
|
Chailey adult pubic pressure flange curved top 32mm | Urinal Systems | Incontinence Appliances | 1 |
|
Chailey adult pubic pressure flange curved top 38mm
22902409119
|
Chailey adult pubic pressure flange curved top 38mm | Urinal Systems | Incontinence Appliances | 1 |
|
Chailey male urinal with rubber bag
22902409111
|
Chailey male urinal with rubber bag | Urinal Systems | Incontinence Appliances | 1 |
|
Chenodeoxycholic acid 250mg capsules
0109010G0AAABAB
|
Chenodeoxycholic acid | Chenodeoxycholic acid | Gastro-Intestinal System | 1 |
|
Child transverse rubber bag
22902409167
|
Child transverse rubber bag | Urinal Systems | Incontinence Appliances | 1 |
|
Chiron flange 38mm
23552405504
|
Chiron flange 38mm | Flanges | Stoma Appliances | 1 |
|
Chiron ostomy plaster 125mm x 125mm 25mm
23052400515
|
Chiron ostomy plaster 125mm x 125mm 25mm | Adhesive Discs/Rings/Pads/Plasters | Stoma Appliances | 1 |
|
Chiron ostomy plaster 127mm x 127mm 35mm
23052400511
|
Chiron ostomy plaster 127mm x 127mm 35mm | Adhesive Discs/Rings/Pads/Plasters | Stoma Appliances | 1 |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.